grade
pharmaceutical primary standard
API family
heparin
manufacturer/tradename
EDQM
application(s)
pharmaceutical (small molecule)
format
neat
storage temp.
2-8°C
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
Application
Heparin calcium for NMR identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Packaging
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
Other Notes
Sales restrictions may apply.
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
涉药品监管产品
此项目有
Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation.
Maria Maroto-Iitani et al.
Contact dermatitis, 52(4), 228-230 (2005-04-30)
G M Andreozzi et al.
Minerva cardioangiologica, 48(12 Suppl 1), 9-14 (2001-03-20)
Thrombophlebitis of the superficial veins (SVT) of the leg is usually regarded as a mild and uncomplicated disease. Although this is generally true for acute thrombosis of the branches of the saphenous vein, the natural history of SVT involving the
F Perfetto et al.
Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 16(3), 179-184 (2001-11-06)
An 80-year-old woman was admitted to the Traumatologic Hospital of Florence because of bilateral post-traumatic humeral fractures. Subcutaneous calcium heparin was immediately administered to prevent deep venous thrombosis. Nine days later, the patient was referred to the Internal Medicine Unit
Pharmacodynamics of the anticoagulant activity (APTT) of an algal polysaccharide.
Franco Cattaneo et al.
Thrombosis research, 105(5), 455-457 (2002-06-14)
Maria Laura Cossu et al.
Chirurgia italiana, 59(3), 331-335 (2007-08-01)
Patients with morbid obesity who undergo bariatric surgery are usually considered at high risk of developing venous thromboembolism. Considering that deep vein thrombosis is often asymptomatic, primary prevention is the key to reducing morbidity and mortality. Between 1995 and 2003
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持